Haolong Qi
- Topics
- Cancer-related molecular mechanisms research (5 papers)Liver Disease Diagnosis and Treatment (3 papers)Nanoplatforms for cancer theranostics (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Haolong Qi
14 papers receiving 320 citations
Peers
Comparison fields: 5 of 54
- Molecular Biology 215
- Cancer Research 188
- Immunology 47
- Oncology 35
- Biomedical Engineering 33
Countries citing papers authored by Haolong Qi
This map shows the geographic impact of Haolong Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haolong Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haolong Qi more than expected).
Fields of papers citing papers by Haolong Qi
This network shows the impact of papers produced by Haolong Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haolong Qi. The network helps show where Haolong Qi may publish in the future.
Co-authorship network of co-authors of Haolong Qi
This figure shows the co-authorship network connecting the top 25 collaborators of Haolong Qi. A scholar is included among the top collaborators of Haolong Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haolong Qi. Haolong Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 30 | |
| 6 | 9 | |
| 7 | Glioma-associated oncogene homolog 1 stimulates FOXP3 to promote non-small cell lung cancer stemness. | 4 |
| 8 | 51 | |
| 9 | 2 | |
| 10 | 16 | |
| 11 | 11 | |
| 12 | 129 | |
| 13 | 5 | |
| 14 | 33 | |
| 15 | 9 | |
| 16 | 18 |
About Haolong Qi
Haolong Qi is a scholar working on Cancer Research, Hepatology and Pharmacology, having authored 16 papers that have together received 321 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Cancer Research (188 citations), Molecular Biology (215 citations) and Immunology (47 citations). Haolong Qi has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yusha Xiao, Quanyan Liu, Yufeng Yuan, Tao Guo, Lei Chang, Zhisu Liu, Cuicui Li, Dong Xu, Yuan Li and Xiaoqing Cai. Their work appears in journals such as Journal of Biological Chemistry, Annals of Oncology and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.